Human Longevity, Inc. ™ (HLI) is the genomics-based, health intelligence company creating the world's largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine. Our DNA determines so much about each of us, but other factors can also influence our health. HLI is focused on compiling and analyzing more genotypic and phenotypic data because the combination of both enables us -to generate unprecedented insights and accelerate our understanding into what makes us who we are and what we can change for a life better lived.
3
Total Investments
3
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Health Care
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Human Longevity
Recent Investments (3)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Jun 2020 | |
| Series B | •••••• | May 2020 | |
| Venture Round | •••••• | May 2016 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.